Attitudes towards ferric derisomaltose among Swiss patients with iron deficiency and their treating physicians: the prospective, observational Real-CHOICE study | Synapse
March 3, 2026Open Access
Attitudes towards ferric derisomaltose among Swiss patients with iron deficiency and their treating physicians: the prospective, observational Real-CHOICE study
Key Points
Patient and physician attitudes towards ferric derisomaltose show significant alignment, fostering treatment acceptance.
Positive feedback from 200 patients highlights the ease of administration and overall satisfaction with ferric derisomaltose.
Observational study design across Switzerland gathers qualitative insights directly from patients and their physicians.
Findings may inform clinical practice and improve iron deficiency management strategies in Switzerland.